Access cutting-edge immunoglobulin a nephropathy (igan) treatment through this phase 2 clinical trial at a research site in Pembroke Pines. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Pembroke Pines location
Preparing your pre-screening questions…
Access immunoglobulin a nephropathy (igan) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related immunoglobulin a nephropathy (igan) treatment provided free
Check if you qualify for this immunoglobulin a nephropathy (igan) clinical trial in Pembroke Pines, FL
No-Cost Study Care
Local to Pembroke Pines
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The study will assess how ARGX-121 affects immunoglobulin A nephropathy (IgAN) disease outcomes, such as renal function, how it is distributed and eliminated from the body, and how the immune system responds in adults with IgAN. While in the study, participants will continue to receive their usual medical care and medications for IgA nephropathy, unless the study doctor confirms otherwise. The study will include a double blinded period, followed by an active drug period, and conclude with a follow up period. The total study duration for participants will be approximately 72 weeks, with a maximum of 52 weeks on ARGX-121.
Sponsor: argenx
Yes, this clinical trial (NCT07773727) has an active research site in Pembroke Pines, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for immunoglobulin a nephropathy (igan) treatment options in Pembroke Pines, FL, this clinical trial (NCT07773727) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pembroke Pines research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced immunoglobulin a nephropathy (igan) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all immunoglobulin a nephropathy (igan) clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in Pembroke Pines — not just this study.
Browse Multiple Myeloma Trials in Pembroke Pines →